Canopy Growth (CGC) Current Leases (2020 - 2026)
Canopy Growth (CGC) posted Current Leases of $10.4 million for Q1 2026, up 13.28% sequentially from $9.2 million in Q4 2025, and down 9.38% YoY from $11.5 million in Q1 2025.
Canopy Growth (CGC) Current Leases (2020 - 2026) Analysis & Trends
Canopy Growth has reported Current Leases for 7 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Current Leases fell 9.38% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (down 9.38% YoY) and the FY2026 annual result came in at $10.4 million, down 9.38% from the prior year.
- Current Leases grew to $10.4 million in Q1 2026 per CGC's latest filing, from $9.2 million in the prior quarter.
- Over five years, Current Leases peaked at $31.6 million in Q2 2024 and troughed at $9.1 million in Q2 2025.
- A 5-year average of $17.8 million and a median of $11.5 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases jumped 196.89% in 2024, then plunged 71.14% in 2025.
- Over 5 years, Current Leases stood at $26.2 million in 2022, then plunged by 60.66% to $10.3 million in 2023, then grew by 29.15% to $13.3 million in 2024, then sank by 30.66% to $9.2 million in 2025, then grew by 13.28% to $10.4 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $10.4 million, $9.2 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 441.18 Mn | 194.17 Mn | 16.08 Mn | 10.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.30 Mn |
| Mar 31, 2026 | 10.45 Mn |
| Dec 31, 2025 | 9.22 Mn |
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 9.11 Mn |
| Mar 31, 2025 | 11.53 Mn |
| Dec 31, 2024 | 13.30 Mn |
| Sep 30, 2024 | 30.87 Mn |
| Jun 30, 2024 | 31.56 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 10.80 Mn |
| Mar 31, 2023 | 21.02 Mn |
| Dec 31, 2022 | 26.18 Mn |
| Sep 30, 2022 | 28.46 Mn |
| Jun 30, 2022 | 29.72 Mn |
| Mar 31, 2022 | 30.03 Mn |
| Dec 31, 2021 | 30.69 Mn |
| Sep 30, 2021 | 29.32 Mn |